UK’s medical royal colleges pride themselves on being world leaders in areas of public health, education, and clinician training. However, a new study shows their mission to address urgent, complex health issues from a cross-specialty perspective may be compromised when money enters the picture.
Experts in the UK are sounding the alarm over the lack of funding transparency from medical royal colleges, saying that failure to disclose the millions of dollars accepted from drug companies like Pfizer and medical devices firms threatens public and doctors’ trust.
